hotspot -WSS

hotspot

author：entertainment 2025-09-27 22:56:35 - browse：9583

BiTE Bridge — Illustration of a BiTE, Amgen's bispecific antibodies Amgen

In cancer immunotherapy these days, technology is advancing so fast that 2017’s buzzy new treatment may soon be passe: Only 18 months after approval of the first CAR-T, pharmaceutical companies and biotechs are already talking about next-generation cancer therapy.

Called bispecific antibodies, they’re being developed by some two dozen companies large and small, with a version cleverly branded as BiTEs already constituting 60 percent of Amgen’s oncology pipeline. The appeal: Bispecifics make the immune system kill tumor cells like first-gen immunotherapy, but, unlike the weeks it takes to laboriously manufacture CAR-Ts, they can start being infused almost as quickly as an oncologist can write a prescription.

“We’re very bullish” on BiTEs, said Dr. David Reese, head of R&D at Amgen, which has the only cancer-targeting bispecific approved for clinical use in the U.S. and 14 more in development, including for multiple myeloma, small cell lung cancer, glioblastoma, and other solid tumors. “We can generate a BiTE against any tumor antigen we want to go after.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why failed clinical trials don’t always spell doom for a new drug

hotspot

WSS

Too many hospitalized Covid

Wegovy’s successful heart trial raises vital question about weight loss

Why Eli Lilly’s earnings didn’t quite live up to the hype

Study gives hint on South Asians’ higher risk of cardiovascular disease

Why failed clinical trials don’t always spell doom for a new drug

Resistance to opioid

knowledge

hotspot

entertainment

Jerome Adams on the need for new antivirals for Covid

Having children helps parents live longer, especially after age 80

As demand for Covid shots wanes, Moderna seeks its next success

Abbott's new heart device gets FDA advisory panel nod

Malaria cases in Florida and Texas: Here’s what you need to know

American woman, child freed after being kidnapped in Haiti last month

Continuity nursing helped my family in our darkest PICU moments

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

focus

South Korea throws huge K

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Abbott's new heart device gets FDA advisory panel nod

Naloxone nonprofit donates 200,000 doses after FDA approval

hotspot

hotspot

Wikipedia

focus